Kardium Stock
Kardium develops medical devices for the diagnosis and treatment of atrial fibrillation.
Sign up today and learn more about Kardium Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Kardium Stock
Kardium is a technology pioneer working to advance medical device technology in the diagnosis and treatment of atrial fibrillation. Kardium was founded in 2007 and has built an outstanding team with a track record of excellence in medicine, business, and engineering. We have hired the best engineers, medical researchers and production staff and have been working with a team of top medical advisors to develop the Globe mapping and ablation system. The Globe system has been entirely developed by the team at Kardium and provides a complete system to assist in the diagnosis and treatment of atrial fibrillation. Kardium is based in Vancouver, Canada, and has consistently ranked as one of the top companies to work for in British Columbia.
Funding History
August 2010 | $868K |
---|---|
April 2014 | $269K |
January 2021 | $115M |
Management
Advisor
John Yeung
Advisor
John Webb
Co-Founder & Advisor
Sam Lichtenstein
CEO
Doug Goertzen
Advisor
Hans Kottkamp
Chairman
Amos Michelson
Advisor
James Abel
Co-Founder & Advisor
Dan Gelbart
Press
finance - Apr, 6 2024
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Studybiospace - Apr, 2 2024
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Studybiv - Jan, 26 2021
B.C. medical device maker Kardium raises US$115m as it eyes IPOdlvr - Jan, 25 2021
B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going publicfiercebiotech - Jul, 2 2020
Kardium nets atrial fibrillation CE mark for its spherical heart ablation catheter